Neuroblastoma (NB), derived from the neural crest (NC), is the most common pediatric extracranial solid tumor. Here we establish a platform that allows studying human NBs in mouse-human NC chimeras. Chimeric mice were produced by injecting human NC cells carrying NB relevant oncogenes in-utero into gastrulating mouse embryos. The mice developed tumors composed of a heterogenous cell population that closely resembled that seen in primary NBs of patients but were significantly different from homogenous tumors formed in xenotransplantation models. The human tumors emerged in immunocompetent hosts and were extensively infiltrated by mouse cytotoxic T cells reflecting a vigorous host anti-tumor immune response. However, the tumors blunted the immune response by inducing infiltration of regulatory T cells and expression of immune checkpoints similar to escape mechanisms seen in human cancer patients. Thus, this experimental platform allows studying human tumor initiation, progression, manifestation and tumor -immune-system interactions in an animal model system.
Introduction
Based on the discovery of cancer immune checkpoints and the success of checkpoint inhibitors, the new generation of cancer immunotherapies have resulted in remarkable advances in cancer treatment. However, the fraction of patients who respond to immune therapy is generally around 20% for the most common solid tumors (Ribas and Wolchock, 2018) calling for model systems that would facilitate studying the parameters that allow tumors to escape immune inhibition. Human cancers are commonly studied in xenotransplantation models involving the injection of human cancer cells or primary tumors into immunocompromised mice. While these models have yielded a wealth of information on the biology of human cancer as well as on therapeutic strategies, they pose several limitations. Because only end stage tumor cells, often adapted to cell growth in culture, are transplanted into host animals that are immune deficient, these xenotransplantation models do not allow investigating the initiation of the tumor and the anti-tumor immune reaction or tumor immune evasion. An alternative experimental approach for studying the anti-cancer immune response in vivo is tumor induction in transgenic mice. However, species specific differences between human and mouse may make it problematic to relate results obtained in transgenic mouse models to human cancer.
Interspecies chimeras represent a promising experimental system for studying human development and disease and may provide the most physiologically relevant environment to study human disease in an in vivo (Jaenisch, 1985 , Huszar et al., 1991 , generated mouse-human neural crest chimeras (Cohen et al., 2016) . Neural crest cells (NCCs) are multipotential, emerge from the neural tube at gastrulation and generate a wide variety of lineages including peripheral neurons, enteric neurons, Schwann cells, melanocytes and cells of adrenal medulla (Bronner and LeDouarin, 2012) . Neural crest (NC) related deficiencies are the cause of multiple human diseases and the term "neurocristopathies" has been proposed to denote syndromes or tumors involving NCCs. Neural crest derived malignancies include cancers such as melanoma, neuroblastoma and neurofibromatosis (Vega-Lopez et al., 2018) and the use of hPSCs-derived NCCs for modeling human NC diseases is an attractive in vitro experimental approach (Fattahi et al., 2016 , Huang et al., 2016 . We showed that hPSCs-derived NCC, when injected into the gastrulating mouse embryo, migrated along the dorso-lateral migration route contributing to the pigment system of the mouse, suggesting that this platform may be used to model neurocristopathies in vivo (Cohen et al., 2016) .
The goal of this work was to model human neuroblastoma (NB), one of the most common extracranial childhood tumors. NB is an embryonal cancer derived from the developing neural crest, with tumors arising in sympathetic ganglia and adrenal medulla (Cheung and Dyer, 2013) . We have generated hPSCs and hNCCs carrying the Doxycycline (Dox) inducible NB-relevant oncogenes MYCN and ALK F1174 (Berry et al., 2012 , Schulte et al., 2013 . When the hNCCs were injected into mouse embryos, tumors resembling primary human NBs were formed. Most significantly, the tumors developed in immunocompetent host mice allowing the analysis of human tumor-immune system interaction and immune escape mechanisms in an experimental animal system.
We found that the host mounts an anti-tumor immune response that is blunted by tumor induced immune inhibitory mechanisms. This chimeric system facilitates the study of critical interactions between NBs and the immune system, in contrast to conventional xenotransplantation assays that rely on immunocompromised host animals and thus preclude meaningful study of the immune response to cancer development.
Results

Generation of human pluripotent cells carrying conditional oncogenes
Previous data have shown that human NC cells injected into E 8.5 embryos migrate along the dorso-lateral migration route and can contribute to the host pigment system in postnatal mice (Cohen et al., 2016) . In these studies, we did not investigate whether the human donor cells can also migrate along the medial NC migration route and contribute to internal structures (Trainor, 2005) . To this end, hNCCs were microinjected into E8. contribute, in addition to the pigment lineage, also to the peripheral nervous system. However, we failed to detect human NC donor cells in structures of the autonomic nervous system such as in the intestine or the adrenal gland.
Because colonization of these structures would require a long migration of the donor cells through the developing embryo, our failure to detect the presence of donor cells at the autonomic nervous system may have been due to low contribution. As shown below, providing the donor NC cells with a proliferative advantage such as expression of NC-tumor relevant oncogenes enhanced detection of rare donor cells contributing to the autonomic nervous system.
We generated hPSCs, which conditionally overexpress MYCN and ALK F1174L to model human neuroblastoma.
MYCN is frequently amplified in high-risk NB and correlates with an aggressive phenotype and poor prognosis (Brodeur et al., 1984 , Seeger et al., 1985 . formation, the hNCCs were injected into immunocompromised mice. Figure 1G shows that Dox dependent expression of the two oncogenes was sufficient to drive tumor formation in immune compromised mice.
Tumor formation in mouse-human neural crest chimeras
To generate mouse-human NC chimeras, the hNCCs were microinjected in-utero into developing mouse embryos at E8.5 as previously described (Jaenisch 1985, Cohen at al., 2016). To activate the oncogenes, Dox was added to the drinking water of the pregnant females at day E9.5-10. (Figure 2A ). To trace cell migration, we inspected embryos at 6 days after injection and found eGFP + donor cell clumps in E-14.5-15.5 injected embryos suggesting cell proliferation of donor cells induced by oncogene activation ( Figure S3 ). We first detected
Luciferase activity in injected mice by using non-invasive bioluminescent imaging in 3 to 6 months old mice, consistent with proliferation of the injected oncogenic cells (Figures 2B-C) . About 20% of the injected mice developed an abdominal mass, mostly from the retroperitoneal space, a typical location seen in NB patients (The total number of mice injected as embryos = 144; See Figure 2C and Figure S4 ) with no macroscopic tumors detected in other organs. Tumors designated as CHNB (Chimeric derived Neuroblastoma) were collected between 3 and 15 months of age (Mean = 10.4 ± 3.9 month) and found to express eGFP, confirming human donor cell origin. Moreover, the tumors immunostained for MYCN, and ALK and expressed tdTomato, verifying oncogenes expression in the human tumors (Figures 2 D-G) . Also, the human tumors were positive for phosphorylated 
Tumors form in immunocompetent recipient mice
In contrast to conventional xenograft models, the human cells were found to form NBs in immunocompetent hosts with the fraction of NB formation (number of tumors in total number of mice injected as embryos) being similar to the fraction in immunocompromised hosts ( Figure S4 ). Growth of human tumors in immunocompetent mice suggests that the hosts were tolerized to the human cells (Xing and Hogquist, 2012). To test this, we investigated the immune-microenvironment of the human NBs that had developed in the immunocompetent mice.
Immuno-histological analysis of NBs growing in adult chimeric mice showed strong infiltration by host (murine) 
Discussion
The results described in this paper show that the human-mouse chimeric platform described here allows to model human neuroblastoma in an animal system. Oncogene induced tumors were heterogenous consisting of multiple cell types similar to primary patient derived NBs. This is in contrast to tumors induced in xenotransplantation models, which are homogenous and are lacking the expression of NB markers typically seen In summary, the NB-bearing mouse-human chimera platform provides a highly defined model for studying the initiation and progression of NB, as well as its tumor immune-microenvironment and the immune-tumor interactions which govern immune evasion. Importantly, the ability to grow clinically derived human NB tumor cells in immune-competent hosts will facilitate the study of critical interactions between high-risk NB and the immune system. Ultimately, the chimeric model system may prove to be an optimal platform for studying NB pathogenesis and enabling the evaluation of different combinations of anti-oncogenic and immune-based therapies. IF samples were imaged using Zeiss LSM 710 confocal microscope. For H&E staining, deparaffinized sections were stained in hematoxylin, incubated with 1% acid alcohol (1% HCl in 70% EtOH) and ammonia water, and stained with 1% Eosin.
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were segmented based on Gaussian blurred images in both haematoxylin and DAB channels respectively using size and intensity thresholds. Cells were then filtered based on the channels overlapping rate, and those which exhibit over 60% overlapping rates, representing cells expressing the tested markers, were scored and quantified. The software pipeline detection was tested to be highly correlated with visual detection.
LacZ staining: Cell were fixed shortly with 2% formaldehyde and 0.5% glutaraldehyde in PBS, and incubated in staining-solution containing 1 mg/ml X-Gal, 5 mM potassium ferricyanide, 5 mM potassium ferrocyanide and 2mM MgCl2, in PBS (All from MilliporeSigma) at 37 0 C, overnight.
Southern Blot: 10µg of DNA isolated from hPSCs was digested overnight with the appropriate enzymes and run on a 0.8% agarose gel. DNA was transferred to a nylon membrane (Amersham) and hybridized with 32P-labeled random primer (Stratagene) probes. 
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